SMFS
ICPT

Squar Milner Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Squar Milner Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-92
Closed -$8K – 876
2018
Q2 		$8K Buy
+92
New +$6.74K 0.01% 637

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Squar Milner Financial Services's ICPT Position: Q3 2018 in Review

Squar Milner Financial Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2018, closing a stake of 92 shares — an estimated $8K sold.

Squar Milner Financial Services first reported a position in ICPT in Q2 2018 and held it in 1 quarter. The position peaked at $8K in Q2 2018. 175 funds tracked by Wall St. Rank hold ICPT as of Q3 2018.

  • Squar Milner Financial Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Squar Milner Financial Services sold 92 Intercept Pharmaceuticals, Inc. shares in Q3 2018, an estimated $8K.
  • Squar Milner Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2018 and held it in 1 quarter.
  • Squar Milner Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $8K in Q2 2018.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2018.

Based on Squar Milner Financial Services's 13F filing for Q3 2018, filed 29 Oct 2018.